PHAXIAM Therapeutics Market Cap

PHAXIAM Therapeutics has a market cap or net worth of €19.03 million as of February 21, 2025. Its market cap has decreased by -11.28% in one year.

Market Cap

19.03M

Enterprise Value

21.82M

Revenue

2.14M

Ranking

n/a

PE Ratio

n/a

Stock Price

€1.89

Market Cap Chart

Since May 7, 2013, PHAXIAM Therapeutics's market cap has decreased from 52.24M to 19.03M, a decrease of -63.58%. That is a compound annual growth rate of -8.20%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	19.03M	12.43%
Dec 31, 2024	16.92M	-39.44%
Dec 29, 2023	27.94M	145.63%
Dec 30, 2022	11.38M	-82.70%
Dec 31, 2021	65.75M	-52.72%
Dec 31, 2020	139.08M	15.73%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
EssilorLuxottica Société anonyme	133.59B
Sanofi	129.85B
Sartorius Stedim Biotech	20.30B
bioMérieux	13.52B
Eurofins Scientific SE	9.30B
Ipsen	8.97B
Virbac	2.55B
emeis Société anonyme	1.48B

Market Cap Rankings